Malvern Panalytical releases Hydro Insight: A deeper level of materials insights
July 6, 2021
Malvern Panalytical, a leading analytical instrumentation supplier, today launches the Hydro Insight, a game-changing dynamic imaging accessory for its Mastersizer 3000 particle sizing instrument. The Hydro Insight provides an ‘extra pair of eyes’ for researchers, scientists, and quality control managers. Through real-time particle imaging, this tool helps them to see beyond particle size – powering [...]
July 6, 2021
VectorBuilder – a global leader in vector design, optimization and GMP manufacturing – has formed a worldwide strategic partnership with Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production. VectorBuilder’s manufacturing center in Guangzhou, China, will work with Univercells Technologies to develop and optimize platform processes for the production [...]
MIMETAS and Roche Enter into a Collaboration to Develop Human Disease Models for Drug Development
July 6, 2021
Risk-sharing alliance on tailor-made phenotypic models for IBD and HBV Upfront payment and milestone payments for MIMETAS Access to know-how on novel disease models and assays for Roche Option to exclusively license of disease models and assays for Roche LEIDEN, The Netherlands -- MIMETAS, a leader in organ-on-chip-based disease models and technology, and Roche, a world-leading pharmaceutical [...]
July 6, 2021
SAN DIEGO -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced significant progress in China with the adoption of its Saphyr® System for optical genome mapping (OGM) by WeHealth Shanghai, a leading provider of genome analysis services in reproductive health. The adoption was announced at the Structural Variation Symposium in Shanghai, organized with support from the Shanghai [...]
July 6, 2021
Chicago/Boston — GE Healthcare and SOPHiA GENETICS today announced that they have signed a letter of intent to collaborate on advancing cancer care, with the goal of better targeting and matching treatments to each patient’s genomic profile and cancer type, helping to ensure the most effective and personalized treatment. The companies aim to develop new artificial intelligence (AI)-powered [...]
New DECTRIS CEO: “Our employees’ knowledge and abilities are our greatest asset”
July 6, 2021
Christian Brönnimann strengthens the DECTRIS management in January 2022 by handing over the CEO’s mantle to CTO Matthias Schneebeli. The decision is only one example of a company-wide trend to distribute responsibilities and leadership, and it’s a natural next growth move after the company delivered a record-high number of X-ray and electron detectors in 2020. Dr. [...]
SomaLogic Customizable Protein Panels With Industry-Leading 7,000-Plex Assay Now Available
July 6, 2021
NEW YORK & BOULDER, Colo. -- CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, Inc., a global leader in proteomics technology, announced today that their new customizable protein panel products are now available to pharma, biotechnology and academic research customers seeking the power of the company’s proteomics menu of 7,000 proteins. "Our customers have expressed [...]
July 2, 2021
Göttingen Portfolio expanded by cell culture components, such as growth factors, cytokines, and media CellGenix site in Freiburg to be expanded into a center of excellence for the development and production of cell culture components The life science group Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer [...]
Techcomp Europe Acquires Majority Shareholding in Mass Spectrometer Manufacturer, Isotopx Limited
July 2, 2021
Techcomp Instruments Limited (“Techcomp”) is delighted to announce that Techcomp Europe has successfully completed the acquisition of a majority shareholding in Isotopx Limited, based in Middlewich, Cheshire. For the past 13 years Isotopx has been at the forefront of mass spectrometer design and innovation. The whole team at Isotopx, led by CEO and founder Zenon [...]
Pall Corporation Secures Multi-Million Dollar Contract With Exothera
July 1, 2021
Manufacturing partnership enables suspension-based manufacture of gene therapies and viral vector-based vaccines PORT WASHINGTON, N.Y. – Pall Corporation, a global leader in filtration, separation and purification, today announced a new contract worth more than $7M with full-service contract development and manufacturing organization (CDMO) Exothera S.A. The new contract with Pall will establish a suspension-based manufacturing platform [...]

